OQROGet OQRO Pro
Insider trade

Roivant Sciences (ROIV)10% owner sold ~$16.8M

Ramaswamy Vivek, 10% owner at Roivant Sciences, sold ~$16.8M of Roivant Sciences shares.

~$16.8M
Approx. value · 774K sh @ $21.64
34.7M
Holds after · shares reported
Traded
Dec 11, 2025
Filed
Dec 16, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 9, 2025InsiderCEO sold ~$1.71M of ROIV shares in the open market
  2. Oct 13, 2025InsiderCEO sold ~$337K of ROIV shares in the open market
  3. Oct 15, 2025InsiderCEO sold ~$7.02M of ROIV shares in the open market
  4. Oct 16, 2025InsiderCEO sold ~$5.43M of ROIV shares in the open market
  5. Oct 17, 2025InsiderCEO sold ~$2.02M of ROIV shares in the open market
  6. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  7. Oct 31, 2025CongressDisclosed sale of ROIV — reported range $1,001 - $15,000
  8. Nov 7, 2025InsiderCEO sold ~$4.04M of ROIV shares in the open market
  9. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  10. Nov 13, 2025Insider10% owner sold ~$5.98M of ROIV shares in the open market
  11. Nov 14, 2025Insider10% owner sold ~$20.9M of ROIV shares in the open market
  12. Nov 17, 2025Insider10% owner sold ~$11.1M of ROIV shares in the open market
  13. Nov 19, 2025Insider · 3 peopleInsiders: 12 sales (~$78.9M)
  14. Dec 9, 2025InsiderCEO sold ~$4.17M of ROIV shares in the open market
  15. Dec 11, 2025 · this disclosureInsider10% owner sold ~$16.8M of ROIV shares in the open market

What came next

  1. Dec 12, 2025Insider · Their largest sale since 202310% owner sold ~$43.4M of ROIV shares in the open market
  2. Dec 15, 2025Insider · 2 peopleInsiders: 4 sales (~$45.5M)
  3. Dec 16, 2025Insider · 3 peopleInsiders: 6 sales (~$63.4M)
  4. Dec 17, 2025Insider · 4 peopleInsiders: 10 sales (~$54.4M)
  5. Dec 23, 2025Insider · 2 peopleInsiders: 3 sales (~$13.6M)
  6. Dec 24, 2025InsiderCEO sold ~$1.69M of ROIV shares in the open market
  7. Dec 29, 2025InsiderDirector sold ~$6.78M of ROIV shares in the open market
  8. Dec 31, 2025Insider · Their largest sale since 2024Director sold ~$22.1M of ROIV shares in the open market
  9. Jan 12, 2026InsiderCEO sold ~$4.38M of ROIV shares in the open market
  10. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
  11. Feb 9, 2026InsiderDirector sold ~$8.99M of ROIV shares in the open market
  12. Feb 11, 2026Insider · 3 peopleInsiders: 3 sales (~$34.0M)
  13. Feb 12, 2026Insider · 3 peopleInsiders: 6 sales (~$34.1M)
  14. Feb 13, 2026Insider · 4 peopleInsiders: 7 sales (~$35.2M)
  15. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
  16. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
  17. Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
  18. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  19. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  20. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Ramaswamy Vivek, 10% owner

The full history of Ramaswamy Vivek, 10% owner is on the profile page.

How this filing works

Other disclosures at Roivant Sciences

Everything OQRO holds on this company is on its ROIV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data